---
title: 'Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed
  or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]'
date: '2024-12-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39627085/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241204174915&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...